SCHEMBL4354007

SCHEMBL4354007

O=C(NC1CCCCC1)N(S)c1cccc(F)c1O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.46
RAB9A P51151 10/20 0.46
KMT2A Q03164 5/20 0.46
PKM P14618 1/20 0.44
MEN1 O00255 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
PPIA P62937 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
EPHX2 P34913 3/20 0.39
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
CCNA2 P20248 1/20 0.39
CDK2 P24941 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27761080 0.84 PKM (0.57) NPC1RAB9AKMT2APKMMEN1
SCHEMBL4353372 0.84 RAB9A (0.46) NPC1RAB9AKMT2APKMMEN1
SCHEMBL4357800 0.84 EPHX2 (0.48) NPC1RAB9AKMT2APKMSMN1; SMN2
SCHEMBL4348879 0.81 ADORA2A (0.43) NPC1RAB9AKMT2AMEN1GAA
SCHEMBL4349504 0.81 NPC1 (0.39) NPC1RAB9AKMT2APKMMEN1
SCHEMBL4341989 0.78 PKM (0.44) NPC1RAB9AKMT2APKMMEN1
SCHEMBL4352149 0.75 ERN1 (0.38) GAAALDH1A1HPGDHTT
SCHEMBL4347655 0.74 MEN1 (0.47) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL27782810 0.74 LMNA (0.46) NPC1RAB9AKMT2APKMMEN1
SCHEMBL4347359 0.74 PKM (0.44) NPC1RAB9AKMT2APKMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 NPC1 815/4885RAB9A 4228/4885KMT2A 2096/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 NPC1 1189/4885RAB9A 4588/4885KMT2A 1254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.